Lentiviral Vector Engineering: Impact on Manufacturing and Vector Performance

被引：0
|
作者：
Formas-Oliveira, Ana S. [1 ]
Vaz, Tiago A. [1 ]
Ferreira, Mariana Valentim [1 ]
Coroadinha, Ana S. [1 ]
机构：
[1] iBET, Oeiras, Portugal
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
283
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [21] The very stable lentiviral vector
    Binder, Gwendolyn K.
    Chen, Chien-Chung
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [22] Construction of shRNA lentiviral vector
    Song, Hong
    Yang, Ping-Chang
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2010, 2 (12) : 598 - 601
  • [23] Progress in Lentiviral Vector Technologies
    Thrasher, Adrian J.
    HUMAN GENE THERAPY, 2013, 24 (02) : 117 - 118
  • [24] OPTIMIZING LENTIVIRAL VECTOR PRODUCTION FOR CELL THERAPIES: ADVANCING MANUFACTURING STRATEGIES AT OMNIABIO
    Al Asafen, H.
    Sudarsan, A. K.
    Mcleod, A.
    Kawka, K.
    Maystrenko, A.
    Sirskyj, D.
    Bagheri, M.
    Attignon, E.
    Chettiar, D.
    Beaudette, P.
    Razvi, A.
    Patel, N.
    McNally, K.
    Gacerez, A.
    Fardy, M.
    CYTOTHERAPY, 2024, 26 (06) : E29 - E30
  • [25] Process intensification for lentiviral vector manufacturing using tangential flow depth filtration
    Tona, Robert M.
    Shah, Reeti
    Middaugh, Kimberly
    Steve, Justin
    Marques, Joao
    Roszell, Blair R.
    Jung, Cindy
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 29 : 93 - 107
  • [26] Engineering Resistance to HIV-1 Infection with a Dual Therapeutic Lentiviral Vector
    Burke, Bryan P.
    Boyd, Maureen P.
    Millington, Michelle L.
    Impey, Helen
    Zhang, Jane
    Carroll, Maria V.
    Camba-Colon, Joanna
    Keech, Naomi
    Delebecque, Frederic
    Wolstein, Orit
    Howe, Annett
    Koldej, Rachel
    Nicolson, Tamara
    Levin, Bernard R.
    Rezek, Valerie
    Vatakis, Dimitrios N.
    Kitchen, Scott G.
    Breton, Louis R.
    Bartlett, Jeffrey S.
    Symonds, Geoff P.
    MOLECULAR THERAPY, 2013, 21 : S20 - S20
  • [27] Enzymatically amplified linear dbDNA™ as a rapid and scalable solution to industrial lentiviral vector manufacturing
    Barreira, Maria
    Kerridge, Claire
    Jorda, Sara
    Olofsson, Didrik
    Neumann, Alexander
    Horton, Helen
    Smith-Moore, Sarah
    GENE THERAPY, 2023, 30 (1-2) : 122 - 131
  • [28] Enzymatically amplified linear dbDNATM as a rapid and scalable solution to industrial lentiviral vector manufacturing
    Maria Barreira
    Claire Kerridge
    Sara Jorda
    Didrik Olofsson
    Alexander Neumann
    Helen Horton
    Sarah Smith-Moore
    Gene Therapy, 2023, 30 : 122 - 131
  • [29] Optimization of Vector Design and Preparation Conditions to Improve the Lentiviral Vector Productivity
    Lu, Hsin-Lin
    Su, Yu-Hua
    Chen, Li-Hao
    Leng, Pei-Ju
    Kao, Ta-Chun
    Teng, Chao-Yi
    Huang, Kao-Jean
    Chi, Wei-Kuang
    MOLECULAR THERAPY, 2020, 28 (04) : 434 - 434
  • [30] A lentiviral/adenoviral hybrid vector; Efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector
    Kubo, S
    Mitani, K
    MOLECULAR THERAPY, 2003, 7 (05) : S180 - S180
12345